Literature DB >> 14007184

Oral calcium disodium versenate in treatment of lead poisoning.

J D WILLIAMS, G A MATTHEWS, A W JUDD.   

Abstract

Entities:  

Keywords:  EDATHAMIL/therapy; LEAD POISONING/therapy

Mesh:

Substances:

Year:  1962        PMID: 14007184      PMCID: PMC1038198          DOI: 10.1136/oem.19.3.211

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


× No keyword cloud information.
  12 in total

1.  The measurement of lead absorption in industry.

Authors:  E KING; A R THOMPSON
Journal:  Ann Occup Hyg       Date:  1961-06

2.  Recent developments in the care of workers exposed to lead; the effect of the calcium chelate of disodium ethylenediamine-tetraacetic acid on lead in the blood and urine of battery workers.

Authors:  I A MANVILLE; R MOSER
Journal:  AMA Arch Ind Health       Date:  1955-11

3.  Effect of oral edathamil calcium-disodium on urinary and fecal lead excretion; comparative excretory studies with intravenous therapy.

Authors:  R F BELL; J C GILLILAND; J R BOLAND; B R SULLIVAN
Journal:  AMA Arch Ind Health       Date:  1956-04

4.  Treatment of chronic lead-poisoning with calcium disodium versenate.

Authors:  A C MARKUS; A G SPENCER
Journal:  Br Med J       Date:  1955-10-08

5.  Oral calcium EDTA in lead intoxication of children.

Authors:  J E BRADLEY; A M POWELL
Journal:  J Pediatr       Date:  1954-09       Impact factor: 4.406

6.  Misuse of edathamil calciumdisodium for prophylaxis of lead poisoning.

Authors:  R A KEHOE
Journal:  J Am Med Assoc       Date:  1955-01-22

7.  The metabolism of C14 labeled ethylenediaminetetraacetic acid in human beings.

Authors:  H FOREMAN; T T TRUJILLO
Journal:  J Lab Clin Med       Date:  1954-04

8.  Treatment of lead poisoning by chelation.

Authors:  L H COTTER
Journal:  J Am Med Assoc       Date:  1954-07-03

9.  Effect of chelating agent on urinary lead excretion; comparison of oral and intravenous administration.

Authors:  J B SIDBURY; J C BYNUM; L L FETZ
Journal:  Proc Soc Exp Biol Med       Date:  1953-02

10.  The diagnostic and therapeutic use of edathamil calcium disodium (EDTA, versene) in excessive inorganic lead absorption.

Authors:  W J LECKIE; S L TOMPSETT
Journal:  Q J Med       Date:  1958-01
View more
  1 in total

Review 1.  The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients.

Authors:  Loris Zamai
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.